Discuss any concerns with your healthcare provider, who can help you make an informed decision based on your individual health situation
Upon completion of rigorous phase-3 trials, the FDA granted approval for tesamorelin therapy in 2010 in HIV-associated lipodystrophy
W., Kashyap, S., & Deppen, J
The Lancet Neurology 2024;19(7):582590
Knowing what side effects to expect and how to handle them makes a big difference in your results
At the end of pharmacological treatment, biochemical analyses, immunohistochemistry analysis, and intravital microscopy of the brain microcirculation were carried out to quantify leukocyteendothelium interactions and to assess structural capillary density, astrocyte coverage on cerebral vessels and microglial activation